Thyrocare Technologies Ltd. News and Updates

Name: Latest research reports of Thyrocare Technologies Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Thyrocare Technologies Ltd.
Rating: 4
Author: ICICI Securities Limited

Keep track of all breaking news on Thyrocare Technologies Ltd. from all sources in a single place.

Load latest

Thyrocare Technologies Ltd.

13 Dec 2023

1265.30

-1.01%

Buy Thyrocare Technologies; target of Rs 740: ICICI Securities

Moneycontrol

ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.

Thyrocare Technologies Ltd. is trading above its 200 day SMA of 948.9

Thyrocare Technologies Ltd.

01 Nov 2023

1265.30

-1.01%

Thyrocare Techn Consolidated September 2023 Net Sales at Rs 148.00 crore, up 9.65% Y-o-Y

Moneycontrol

Thyrocare Technologies Ltd. is trading below its 30 day SMA of 1300.0

Thyrocare Technologies Ltd.

01 Nov 2023

1265.30

-1.01%

Operations revitalising; mounting debt a concern

Accumulate: Thyrocare Technologies Ltd.

Target

ICICI Securities Limited

Thyrocare’s Q2FY24 performance was in line with our expectations. Its revenue grew 9.7% YoY while the franchisee business grew faster at 20%. It reported an improvement in gross margins (+100bps YoY) due to a decline in the lowmargin Partnership business.

Thyrocare Technologies Ltd. has gained 44.46% in the last 1 Year

Thyrocare Technologies Ltd.

31 Oct 2023

1265.30

-1.01%

Thyrocare Technologies Results Earnings Call for Q2FY24

Conference Call with Thyrocare Technologies Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript.

audio

Thyrocare Technologies Ltd.

03 Aug 2023

1265.30

-1.01%

Thyrocare Technologies shares dip on weak Q1 results

Business Line

Thyrocare Technologies reports 20% decline in profit for June quarter

Thyrocare Technologies Ltd. is trading below its 30 day SMA of 1300.0

Thyrocare Technologies Ltd.

02 Aug 2023

1265.30

-1.01%

Thyrocare Tech tumbles 3% on weak Q1 earnings show

Moneycontrol

Thyrocare Tech attributed the growth slowdown to a closure of the contract from Municipal Corporation of Greater Mumbai (MCGM) and a dip in its API (Active Pharmaceutical Ingredients) business

Thyrocare Technologi.. has an average target of 1000.00 from 1 broker.

Thyrocare Technologies Ltd.

02 Aug 2023

1265.30

-1.01%

Revamping business model to restore margins

Accumulate: Thyrocare Technologies Ltd.

Recommendation Target

ICICI Securities Limited

Thyrocare Technologies has reported an improvement in gross margin (+270bps YoY) in Q1FY24 led by a decline in low margin partnership business. The company has revamped incentive structure offered to franchisees and this should drive a strong 12-14% volume growth in this segment.

Thyrocare Technologi.. has an average target of 1000.00 from 1 broker.

Thyrocare Technologies Ltd.

05 Jul 2023

1265.30

-1.01%

Manipal Group offers to inject Rs 1,000 cr in PharmEasy owner API Holdings: Report

Business Today

It is important to note that API Holdings has to repay a debt of Rs 2,500 crore. Previously, the company had pledged the shares of its subsidiary Thyrocare to Goldman Sachs as collateral for this debt.

Thyrocare Technologi.. has an average target of 1000.00 from 1 broker.

Thyrocare Technologies Ltd.

20 Jun 2023

1265.30

-1.01%

Thyrocare spurts after 5% equity changes hands

Moneycontrol

The deal comes two weeks after the company met with Artisan Partners and Grandeur Peak Global Fund

Thyrocare Technologies Ltd. has gained 74.49% in the last 6 Months

Thyrocare Technologies Ltd.

09 Jun 2023

1265.30

-1.01%

Nomura India's head of investment banking steps down

Business Today

During his tenure at the company, Oza played a key role in various deals, including Nomura's sale of ASK Group to Blackstone and the sale of diagnostics firm Thyrocare to healthcare firm PharmEasy.